JP2017509630A - プロゲステロン製剤 - Google Patents

プロゲステロン製剤 Download PDF

Info

Publication number
JP2017509630A
JP2017509630A JP2016557059A JP2016557059A JP2017509630A JP 2017509630 A JP2017509630 A JP 2017509630A JP 2016557059 A JP2016557059 A JP 2016557059A JP 2016557059 A JP2016557059 A JP 2016557059A JP 2017509630 A JP2017509630 A JP 2017509630A
Authority
JP
Japan
Prior art keywords
progesterone
pharmaceutical composition
solubilized
certain embodiments
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016557059A
Other languages
English (en)
Japanese (ja)
Inventor
カカス ジャニス
カカス ジャニス
パーシカナー ピーター
パーシカナー ピーター
ソルスティンソン トールスティン
ソルスティンソン トールスティン
サンシリオ フレデリック
サンシリオ フレデリック
アマディオ ジュリア
アマディオ ジュリア
バーニック ブライアン
バーニック ブライアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TherapeuticsMD Inc
Original Assignee
TherapeuticsMD Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TherapeuticsMD Inc filed Critical TherapeuticsMD Inc
Publication of JP2017509630A publication Critical patent/JP2017509630A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
JP2016557059A 2014-03-28 2015-03-27 プロゲステロン製剤 Pending JP2017509630A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461972068P 2014-03-28 2014-03-28
US61/972,068 2014-03-28
PCT/US2015/023041 WO2015148952A1 (fr) 2014-03-28 2015-03-27 Formulations de progestérone

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019126362A Division JP2019206540A (ja) 2014-03-28 2019-07-05 プロゲステロン製剤

Publications (1)

Publication Number Publication Date
JP2017509630A true JP2017509630A (ja) 2017-04-06

Family

ID=54196452

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016557059A Pending JP2017509630A (ja) 2014-03-28 2015-03-27 プロゲステロン製剤
JP2019126362A Pending JP2019206540A (ja) 2014-03-28 2019-07-05 プロゲステロン製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019126362A Pending JP2019206540A (ja) 2014-03-28 2019-07-05 プロゲステロン製剤

Country Status (10)

Country Link
EP (1) EP3122364A4 (fr)
JP (2) JP2017509630A (fr)
KR (1) KR20160137597A (fr)
AR (1) AR099872A1 (fr)
AU (1) AU2015237243A1 (fr)
CA (1) CA2942568A1 (fr)
IL (1) IL247828A0 (fr)
MX (1) MX2016011706A (fr)
RU (1) RU2016136666A (fr)
WO (1) WO2015148952A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220105107A1 (en) * 2020-10-01 2022-04-07 Michael Liguori Bioidentical progesterone cream infused with nanoemulsified cbd

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020081726A1 (fr) * 2018-10-17 2020-04-23 Stadler Sarah Sheehan Procédés de traitement de symptômes de la ménopause en utilisant de la progestérone à faible dose
CN112336699A (zh) * 2019-08-09 2021-02-09 南京科宁检测科技有限公司 一种黄体酮阴道缓释软胶囊及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119198A1 (en) * 2000-07-24 2002-08-29 Ping Gao Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
US20030077297A1 (en) * 1999-02-26 2003-04-24 Feng-Jing Chen Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
WO2013192248A1 (fr) * 2012-06-18 2013-12-27 Therapeuticsmd, Inc. Formulations de progestérone

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP2005526083A (ja) * 2002-03-14 2005-09-02 ワトソン ファーマシューティカルズ， インコーポレイテッド プロゲステロンの経口薬物送達システム
EA015155B1 (ru) * 2005-05-26 2011-06-30 Тева Вуменс Хелс, Инк. Дозированные формы для перорального применения, содержащие прогестерон, и способы их изготовления и использования
US20110312927A1 (en) * 2010-06-18 2011-12-22 Satish Kumar Nachaegari Progesterone Containing Oral Dosage Forms and Related Methods
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US9301920B2 (en) * 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) * 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030077297A1 (en) * 1999-02-26 2003-04-24 Feng-Jing Chen Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US20020119198A1 (en) * 2000-07-24 2002-08-29 Ping Gao Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
WO2013192248A1 (fr) * 2012-06-18 2013-12-27 Therapeuticsmd, Inc. Formulations de progestérone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220105107A1 (en) * 2020-10-01 2022-04-07 Michael Liguori Bioidentical progesterone cream infused with nanoemulsified cbd

Also Published As

Publication number Publication date
AR099872A1 (es) 2016-08-24
IL247828A0 (en) 2016-11-30
JP2019206540A (ja) 2019-12-05
KR20160137597A (ko) 2016-11-30
EP3122364A1 (fr) 2017-02-01
AU2015237243A1 (en) 2016-09-29
MX2016011706A (es) 2017-05-01
RU2016136666A3 (fr) 2018-11-07
RU2016136666A (ru) 2018-05-03
CA2942568A1 (fr) 2015-10-01
WO2015148952A1 (fr) 2015-10-01
EP3122364A4 (fr) 2017-10-25

Similar Documents

Publication Publication Date Title
US10639375B2 (en) Progesterone formulations
JP7198177B2 (ja) 天然の併用ホルモン補充療法剤及び治療
US20230062295A1 (en) Vaginal inserted estradiol pharmaceutical compositions and methods
US11865179B2 (en) Progesterone formulations having a desirable PK profile
JP6285866B2 (ja) 天然複合ホルモン補充製剤および療法
US10806697B2 (en) Vaginal inserted estradiol pharmaceutical compositions and methods
US20190381068A1 (en) Progesterone formulations having a desirable pk profile
JP2019206540A (ja) プロゲステロン製剤
CA2926342A1 (fr) Compositions pharmaceutiques a base d'estradiol pour insertion vaginale et methodes associees
JP6680672B2 (ja) 膣挿入されるエストラジオール薬学的組成物及び方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180326

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190108

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190405

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190917